Levitas Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Ernakulam, Kerala, India, established in 2013.
2013 Ernakulam, Kerala, India Active
Last Updated:
Access Report
About Levitas Pharmaceuticals Private Limited

Levitas Pharmaceuticals Private Limited, a active private limited company, was established on 09 April 2013 in Ernakulam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230KL2013PTC033766. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.98 M.

Formerly known as Zeus Fashions Private Limited. It upholds a compliant status. Employing 2 professional, Its leadership includes Shinu (Director), Jino Paul (Director), Kalayil Varghese Siji (Managing Director). Past directors included Manoj Mathew, Muhammed Musthafa, Chris Francis. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at 49/1251A, Ground Floor, Kaithakkal Building Nr.Dawson Vihar, Thykoodam, Vyttila, Ernakulam, Kerala, 682019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KL2013PTC033766

  • Registration Number

    033766

  • Incorporation Date

    09 April 2013

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.98 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.98 M
  • Company Age 12 Year, 10 Months
  • Last Filing with ROC 31 Mar 2018
  • Open Charges ₹ 2.50 M
  • Revenue Growth **** 13.95%
  • Profit Growth **** 249.68%
  • Ebitda **** 67.64%
  • Net Worth 122.62%
  • Total Assets **** 14.85%
Company report

Levitas Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Levitas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Levitas Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shinu Director 27 Jun 2019 Current
Jino Paul Director 24 Mar 2022 Current
Kalayil Varghese Siji Managing Director 29 Oct 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Jun 2019 Past
Pramod Abcsdd Director 27 Sep 2017 Past
Pramod Abcsdd Director 29 Oct 2015 Past
Pramod Abcsdd Director 09 Mar 2016 Past
Pramod Abcsdd Director 29 Oct 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Levitas Pharmaceuticals.

Levitas Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 13.95% increase. The company also saw a substantial improvement in profitability, with a 249.68% increase in profit. The company's net worth Soared by an impressive increase of 122.62%.

Levitas Pharmaceuticals revenue growth over time
Levitas Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.95%
*******
*******
*******
*******
Revenue from Operations
*******
 25.97%
*******
*******
*******
*******
Total Assets
*******
 14.85%
*******
*******
*******
*******
Profit or Loss
*******
 249.68%
*******
*******
*******
*******
Net Worth
*******
 122.62%
*******
*******
*******
*******
EBITDA
*******
 67.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Levitas Pharmaceuticals?

In 2018, Levitas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
23 Nov 2018 Others ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Levitas Pharmaceuticals?

Levitas Pharmaceuticals has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Levitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Levitas Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Levitas Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Jino Paul was appointed as a Director was appointed as a Director on 24 Mar 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Director Appointment

    The activity Shinu was appointed as a Director was appointed as a Director on 27 Jun 2019 & has been associated with this company since 6 years 8 months . was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100217247 was registered on 23 Nov 2018. was documented.

  • Annual General Meeting

    Progress on Levitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    Levitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ernakulam. was recorded as a recent event.

  • Director Appointment

    Progress on Kalayil Varghese Siji was appointed as a Managing Director was appointed as a Managing Director on 29 Oct 2015 & has been associated with this company since 10 years 4 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Levitas Pharmaceuticals Private Limited?

The CIN of Levitas Pharmaceuticals Private Limited is U24230KL2013PTC033766.

Where is Levitas Pharmaceuticals Private Limited headquartered?

Levitas Pharmaceuticals Private Limited is headquartered at 49/1251A, Ground Floor, Kaithakkal Building Nr.Dawson Vihar, Thykoodam, Vyttila, Ernakulam, Kerala, 682019.

When was Levitas Pharmaceuticals Private Limited incorporated?

Levitas Pharmaceuticals Private Limited was incorporated on 09 April 2013.

Who are the current directors of Levitas Pharmaceuticals Private Limited?

The current directors of Levitas Pharmaceuticals Private Limited are

What is the primary industry of Levitas Pharmaceuticals Private Limited?

The primary industry of Levitas Pharmaceuticals Private Limited is Trade.

Is Levitas Pharmaceuticals Private Limited a listed company?

Levitas Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Levitas Pharmaceuticals Private Limited?

The authorized capital of Levitas Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.98 M.

What is the compliance status of Levitas Pharmaceuticals Private Limited?

The compliance status of Levitas Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available